1. Duff JM**, Moreb JS, Muwalla F. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug re-exposure. The Annals of Pharmacotherapy, 2011, In press

2. Moreb JS, Salmasinia D, Hsu J, Hou W, Cline C, Rosenau E. Long-term outcome after autologous stem cell transplantation with adequate peripheral blood stem cell mobilization using plerixafor and G-CSF in poor mobilizer lymphoma and myeloma patients. Advances in Hematology 2011, In Press.

3. Katz J,Gong y, Salmasinia D, Hou W, Burkley B,Ferreira P, Casanova O,Langaee TY, Moreb JS. Genetic Polymorphisms Associated with Bisphosphonate induced Osteonecrosis of the Jaw (BONJ) – A Cohort Study. International Journal of Oral & Maxillofacial Surgery 2011; 40:605-611.

4. Han S, Wang Y, Wang B, Patel E, Okada S, Yang L-J, Moreb JS,Chang L-J.Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells. Journal of Immune Based Therapies and Vaccines 2010; 8:8.

5. Salmasinia D*, Wingard JR, Chang M, Moreb JS. Combination of IFN-α/GM-CSF as a maintenance therapy for multiple myeloma patients after autologous stem cell transplantation (ASCT): A prospective phase II study. Clinical Medicine Insights: Oncology 2010; 4:117–125.